Given its role in the KLM, it is unsurprising that knockdown of CNN2 preserved kidney function, reduced cell death and inflammation, mitigated AKI, and improved the long-term kidney outcomes (Figures 2 and 3 and Supplemental Figures 2 and 3). The gene discussed is CNN2; the disease is acute kidney injury.